A.R.T. Advisors’s Genomic Health, Inc. GHDX Stock Holding History

A.R.T. Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-16,678	Closed	-$1.17M	–	1790
2019 Q1	$1.17M	Buy	16,678 +8,500	+104%	+$630K	0.07%	425
2018 Q4	$527K	Buy	+8,178	New	+$573K	0.03%	705
2018 Q3	–	Sell	-31,871	Closed	-$1.61M	–	1867
2018 Q2	$1.61M	Sell	31,871 -1,622	-5%	-$64.4K	0.07%	443
2018 Q1	$1.05M	Buy	+33,493	New	+$1.11M	0.04%	646
2017 Q3	–	Sell	-8,478	Closed	-$275K	–	1843
2017 Q2	$275K	Buy	8,478 +1,900	+29%	+$60.2K	0.01%	1040
2017 Q1	$207K	Sell	6,578 -15,722	-71%	-$465K	0.01%	1158
2016 Q4	$655K	Buy	+22,300	New	+$680K	0.04%	636
2016 Q2	–	Sell	-15,580	Closed	-$385K	–	1776
2016 Q1	$385K	Sell	15,580 -28,700	-65%	-$788K	0.02%	956
2015 Q4	$1.56M	Buy	+44,280	New	+$1.19M	0.07%	375
2014 Q2	–	Sell	-12,215	Closed	-$321K	–	1641
2014 Q1	$321K	Sell	12,215 -10,364	-46%	-$297K	0.02%	962
2013 Q4	$660K	Buy	22,579 +12,616	+127%	+$400K	0.04%	658
2013 Q3	$304K	Buy	+9,963	New	+$333K	0.02%	971

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

A.R.T. Advisors's GHDX Position: Q2 2019 in Review

A.R.T. Advisors sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 16,678 shares — an estimated $1.17M sold.

A.R.T. Advisors first reported a position in GHDX in Q3 2013 and held it in 12 quarters. The position peaked at $1.61M in Q2 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

A.R.T. Advisors reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
A.R.T. Advisors sold 16,678 Genomic Health, Inc. shares in Q2 2019, an estimated $1.17M.
A.R.T. Advisors first reported a position in Genomic Health, Inc. in Q3 2013 and held it in 12 quarters.
A.R.T. Advisors's Genomic Health, Inc. position peaked at $1.61M in Q2 2018.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on A.R.T. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.